Atacand filed for heart failure in US
July 8, 2004AstraZeneca has submitted its cardiovascular drug Atacand for an additional US licence to treat heart failure.Atacand (candesartan) is one of …
Pfizer’s next blockbuster Lyrica receives European approval
July 8, 2004Pfizer's potential central nervous system blockbuster Lyrica (pregabalin) has received European marketing approval.The drug has received licences for the treatment …
Pfizer UK recruiting for new customer-focused salesforce
July 8, 2004NHS, Pfizer, salesforce
Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …
Everyday diseases and everyday solutions
July 8, 2004What is all the fuss about chronic disease management? Go to virtually any NHS conference these days and you will …
Growing doubts over reliability of HRT trial conclusions
July 6, 2004Influential publicly-funded trials into HRT which convinced millions of women to stop taking the treatment could be flawed, researchers from …
Labour stakes its reputation on NHS Plan part II
July 6, 2004The government has unveiled a plan for the second half of the 10-year period covered by the NHS Plan, claiming …
Unveiled: how to win their attention
July 2, 2004Sir Arthur Conan Doyle once wrote: "It is a capital mistake to theorise before one has data. Insensibly one begins …
Takeda to launch ‘radically different’ approach to NHS
July 2, 2004NHS, Takeda, salesforce
Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …
Novartis rivals find VALUE in landmark Diovan trial
July 1, 2004A landmark study comparing Novartis' Diovan with Pfizer's calcium channel blocker Istin has ended with both sides claiming superiority for …
Pharma’s reputation continues to slide
July 1, 2004The reputation of the pharmaceutical industry in the US continues to decline as the public grows increasingly concerned about the …
Fast4wD expands clinical trial focus
July 1, 2004Ogilvy Public Relations Worldwide and Shire Health Group have merged part of their operations to form Fast4wD Ogilvy, a clinical …
US parallel trade to be legalised after Republican U-turn
June 29, 2004Re-importation of cheaper medicines from Canada and other countries into the US looks certain to be legalised after the Bush …
Sanofi executives take control of new boardroom
June 24, 2004The soon to be created Sanofi-Aventis will be dominated by executives from Sanofi-Synthelabo who have pledged to deliver "swift integration" …
GlaxoSmithKline to publish trial data online
June 24, 2004GlaxoSmithKline has announced it is to make data from all of its trials available online in an effort to counter …
Contract research looks East
June 24, 2004Contract research organisations (CRO) have benefited from the pressure on the pharmaceutical industry to maintain a flow of blockbusters at …
Study finds dementia risk for HRT
June 24, 2004A new study has found that both oestrogen-only and oestrogen plus progestogen hormone replacement therapies may increase the risk of …
Positive opinion on Raptiva in Europe
June 24, 2004Raptiva, a new psoriasis treatment to be marketed by Serono in Europe has gained a positive opinion from the EMEA.The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
